SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Lupus
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Gedalia, A
Right arrow Articles by Gharavi, A E
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gedalia, A
Right arrow Articles by Gharavi, A E
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Lupus
*Sarcoidosis
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Anticardiolipin antibodies in childhood rheumatic disorders

A Gedalia

J F Molina

C O García

S Doggett

L R Espinoza

A E Gharavi

Departments of Pediatrics and Medicine, LSU Medical Center and Children's Hospital, New Orleans, LA

Anticardiolipin antibodies (aCL) have been reported to occur in a wide variety of autoimmune and non-autoimmune disorders in adults.

Our objective was to investigate the prevalence and isotype distribution of aCL and its relationship with the features of antiphospholipid syndrome (APS) in childhood rheumatic disorders.

Between November 1995 and May 1996, all patients who visited our paediatric rheumatology clinic whose guardians signed a consent form participated in the study. The study population included 106 patients (36 systemic lupus erythematosus (SLE), 28 juvenile rheumatoid arthritis (JRA), 11 fibromyalgia, 7 sarcoidosis, 5 dermatomyositis, 3 rheumatic fever (RF), 3 vasculitis, 2 scleroderma, and 11 miscellaneous). aCL measurements were performed by enzyme linked immunoabsorbent assay (ELISA). All patients were carefully evaluated for symptoms and signs of APS.

Eighteen of the 106 patients (17%) were tested positive for one or more of the three aCL isotypes. In SLE, aCL were found positive in 13 of 36 (37%); in JRA 2 of 28 (7%); in sarcoidosis 2 of 7; and in RF 1 of 3. aCL of IgG isotype were found positive in 16 patients (11 SLE, 2 sarcoidosis, 2 JRA, and 1 RF). This isotype was usually detected at low titers (16–24 GPL). aCL of IgM isotype were found positive in five patients (2 sarcoidosis, 2 SLE, 1 JRA), and aCL of IgA isotype were found positive in only three patients (2 SLE, 1 sarcoidosis). Clinical features of APS were rarely seen in our SLE population and were not associated with the presence of aCL. None of the patients in the other groups exhibited any clinical manifestations of APS.

In conclusion, aCL were found in 37% of our childhood SLE patients as compared with only 7% in JRA. These were mostly aCL of IgG isotype of low titers and therefore were not associated with the main features of APS. Prospective studies with a larger sample size may be needed to ascertain the exact prevalence and clinical significance of aCL in childhood-onset SLE.

Key Words: anticardiolipin antibodies • antiphospholipid syndrome • childhood-SLE • childhood rheumatic disorders

Lupus, Vol. 7, No. 8, 551-553 (1998)
DOI: 10.1191/096120398678920659


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
LupusHome page
T. Avcin and E. Silverman
Review: Antiphospholipid antibodies in pediatric systemic lupus erythematosus and the antiphospholipid syndrome
Lupus, August 1, 2007; 16(8): 627 - 633.
[Abstract] [PDF]


Home page
LupusHome page
Y Uziel, N Gorodnitski, M Mukamel, S Padeh, R Brik, J Barash, D Mevorach, Y Berkun, T Tauber, J Press, et al.
Lupus around the World: Outcome of a national Israeli cohort of pediatric systemic lupus erythematosus
Lupus, February 1, 2007; 16(2): 142 - 146.
[Abstract] [PDF]


Home page
Ann Rheum DisHome page
T Avcin, R Cimaz, F Falcini, F Zulian, G Martini, G Simonini, V Porenta-Besic, G Cecchini, M O Borghi, and P L Meroni
Prevalence and clinical significance of anti-cyclic citrullinated peptide antibodies in juvenile idiopathic arthritis
Ann Rheum Dis, July 1, 2002; 61(7): 608 - 611.
[Abstract] [Full Text] [PDF]


Home page
LupusHome page
H Ilarraza, M F Marquez, A Alcocer, J L Banales, A H Nava, and P A Reyes
Anticardiolipin antibodies are not associated with rheumatic heart disease
Lupus, December 1, 2001; 10(12): 873 - 875.
[Abstract] [PDF]


Home page
J Child NeurolHome page
N. Besbas, B. Anlar, A. Apak, and T. Kansu
Optic Neuropathy in Primary Antiphospholipid Syndrome in Childhood
J Child Neurol, September 1, 2001; 16(9): 690 - 693.
[Abstract] [PDF]



Advertisement